<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xml:base="https://www.performance.gov/rssfeedtest/47231" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#">
  <channel>
    <title>RSS Feed</title>
    <link>https://www.performance.gov/rssfeedtest/47231</link>
    <description></description>
    <language>en</language>
     <atom:link href="https://www.performance.gov/performance_rssfeed/47231?content_year_filter=All&amp;type_1=All" rel="self" type="application/rss+xml" />
      <item>
    <title>Reduce opioid-related morbidity and mortality</title>
    <link>https://www.performance.gov/Reduce%20opioid-related%20morbidity%20and%20mortality</link>
    <description>&lt;p&gt;To reduce opioid-related morbidity and mortality: By September 30th, 2017, opioid-related overdose death and opioid use disorder will be addressed through the three priority areas of reforming opioid prescribing practices, increasing the use of naloxone, and expanding access to and use of MAT for opioid use disorders.&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;Decrease by 10% the total morphine milligram equivalents (MME) dispensed in the U.S. outpatient retail pharmacy setting.&lt;/li&gt;
&lt;li&gt;Increase by 15% the number of prescriptions dispensed for naloxone in the U.S. outpatient retail pharmacy setting&lt;/li&gt;
&lt;li&gt;Increase by 10% the number of unique patients receiving prescriptions for buprenorphine and naltrexone in the U.S. outpatient retail pharmacy setting.&lt;/li&gt;
&lt;/ul&gt;</description>
     <pubDate>01/03/2017 11:29:15</pubDate>
 <dc:creator>47231</dc:creator>
 <guid isPermaLink="false">47231</guid>
  </item>
  </channel>
</rss>
